JP2022513152A5 - - Google Patents

Info

Publication number
JP2022513152A5
JP2022513152A5 JP2021530284A JP2021530284A JP2022513152A5 JP 2022513152 A5 JP2022513152 A5 JP 2022513152A5 JP 2021530284 A JP2021530284 A JP 2021530284A JP 2021530284 A JP2021530284 A JP 2021530284A JP 2022513152 A5 JP2022513152 A5 JP 2022513152A5
Authority
JP
Japan
Prior art keywords
mypop
cancer
seq
myb
transcription factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021530284A
Other languages
English (en)
Japanese (ja)
Other versions
JP7642538B2 (ja
JP2022513152A (ja
Filing date
Publication date
Priority claimed from US16/206,526 external-priority patent/US20200174016A1/en
Application filed filed Critical
Publication of JP2022513152A publication Critical patent/JP2022513152A/ja
Publication of JP2022513152A5 publication Critical patent/JP2022513152A5/ja
Application granted granted Critical
Publication of JP7642538B2 publication Critical patent/JP7642538B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021530284A 2018-11-30 2019-11-28 腫瘍療法の診断マーカー及び治療標的としてのMyb関連転写因子(MYPOP) Active JP7642538B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/206,526 2018-11-30
US16/206,526 US20200174016A1 (en) 2018-11-30 2018-11-30 Myb-related transcription factor (mypop) as diagnostic marker and therapeutic target for tumor therapy
PCT/EP2019/082845 WO2020109439A1 (en) 2018-11-30 2019-11-28 Myb-related transcription factor (mypop) as diagnostic marker and therapeutic target for tumor therapy

Publications (3)

Publication Number Publication Date
JP2022513152A JP2022513152A (ja) 2022-02-07
JP2022513152A5 true JP2022513152A5 (cg-RX-API-DMAC7.html) 2023-01-11
JP7642538B2 JP7642538B2 (ja) 2025-03-10

Family

ID=68848224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021530284A Active JP7642538B2 (ja) 2018-11-30 2019-11-28 腫瘍療法の診断マーカー及び治療標的としてのMyb関連転写因子(MYPOP)

Country Status (5)

Country Link
US (2) US20200174016A1 (cg-RX-API-DMAC7.html)
EP (1) EP3887550B1 (cg-RX-API-DMAC7.html)
JP (1) JP7642538B2 (cg-RX-API-DMAC7.html)
CA (1) CA3121047A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020109439A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117164693A (zh) * 2022-05-28 2023-12-05 上海交通大学医学院附属仁济医院 真核翻译起始因子4a1截短体及用途和检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2721179A4 (en) * 2011-06-16 2014-10-01 Caris Life Sciences Luxembourg Holdings S A R L BIOMARKER COMPOSITIONS AND METHOD THEREFOR

Similar Documents

Publication Publication Date Title
US7507532B2 (en) Cancer specific gene MH15
WO2014017491A1 (ja) Cep55遺伝子とret遺伝子との融合遺伝子
JPWO2014007369A1 (ja) Fgfr2融合遺伝子
CN101246169B (zh) 口腔鳞癌诊断试剂、试剂盒及防治药物
KR20080114683A (ko) 질병에 대한 바이오마커로서의 지방생성 아데노바이러스
JP2023123748A (ja) 転移性癌の診断及び治療の方法
CN109022461B (zh) 一种PTEN基因的上游开放阅读框45aa-uORF核苷酸序列及其编码的多肽的应用
CN101768214B (zh) 一种人肿瘤标志物-Tim17多肽及其用途
US20160267244A1 (en) Methods of predicting cancer lethality using replikin counts
WO2009116860A1 (en) Markers providing prognosis of metastasis among cancer patients
CN111139299B (zh) Josd2蛋白在制备治疗恶性肿瘤药物中的应用
EP2320932B1 (en) Methods of predicting cancer lethality using replikin counts
CN113528667B (zh) 一种骨巨细胞瘤的诊断方法
CN111424092B (zh) 一种检测基因及其应用
CN111617247A (zh) 表皮生长因子受体激酶底物8类蛋白3在增强多靶点激酶抑制剂疗效中的用途
JP5316749B2 (ja) シスプラチン耐性遺伝子診断方法及びシスプラチン治療効果遺伝子診断キット
EP1905780B1 (en) Cancer suppressing agent
CN107723369B (zh) Setd1b蛋白及其编码基因在肝癌诊断治疗中的应用
CN109022462B (zh) 一种PTEN基因的上游开放阅读框31aa-uORF核苷酸及其编码的多肽的应用
CN112661826A (zh) 小肽ERpeptide及其在急性髓系白血病中的应用
WO2021043340A2 (zh) 一种肿瘤标志物aquaporin 2蛋白及其应用
JP6839707B2 (ja) Gpr160を過剰発現する癌の予防、診断および治療
JP5622156B2 (ja) シスプラチン耐性遺伝子診断方法及びシスプラチン治療効果遺伝子診断キット
JP2022513152A (ja) 腫瘍療法の診断マーカー及び治療標的としてのMyb関連転写因子(MYPOP)
CN113398270B (zh) 一种治疗骨巨细胞瘤的方法